Invesco Biotechnology & Genome ETF
PBE
PBE
73 hedge funds and large institutions have $53.9M invested in Invesco Biotechnology & Genome ETF in 2018 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 13 increasing their positions, 16 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
73
Holders Change
-1
Holders Change %
-1.35%
% of All Funds
1.67%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
13
Reduced
16
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
UBS Group
Zurich,
Switzerland
|
$6.81M |
2 |
Wells Fargo
San Francisco,
California
|
$4.68M |
3 |
Citadel Advisors
Miami,
Florida
|
$730K |
4 |
CWM
Cornerstone Wealth Management
St. Peters,
Missouri
|
$353K |
5 |
OC
Oppenheimer & Co
New York
|
$282K |